A ngiogenesis involves complex endothelial cell (EC) behaviors, such as proliferation, survival, migration, and tube formation. The most important stimulus promoting angiogenesis is tissue hypoxia. Hypoxia mediates several processes in ECs that are required for each step of angiogenesis.
A ngiogenesis involves complex endothelial cell (EC) behaviors, such as proliferation, survival, migration, and tube formation. The most important stimulus promoting angiogenesis is tissue hypoxia. Hypoxia mediates several processes in ECs that are required for each step of angiogenesis. 1 Hypoxia-induced angiogenesis is closely related to pathological situation. The dysregulation of these EC behaviors and thus abnormal angiogenesis are critically associated with hypoxia-induced pathological angiogenesis that occurs during the course of several diseases, such as cancer and vascular retinopathy. 2, 3 Therefore, identification of specific molecules involved in hypoxia-induced angiogenesis will facilitate studies to clarify the various molecular mechanisms involved in pathological angiogenesis and may aid the discovery of novel angiogenic drug targets.
Cellular responses to hypoxic stress are mediated by multiple mechanisms. Hypoxia-inducible factor-1 (HIF-1) is the most prominent factor that mediates cellular responses to hypoxia by inducing the expression of several target genes. 1 Because HIF-1 activation is preferentially modulated by changes in the amount of the HIF-1α subunit, several factors and mechanisms have been suggested. Among these, the regulation of HIF-1α degradation through post-translational modification by oxygen-sensor proteins and subsequent proteasomal degradation has been well studied. However, although several regulatory mechanisms have been suggested for HIF-1α synthesis, the exact mechanism is yet to be elucidated. 4 Phospholipase D2 (PLD2) is an enzyme that hydrolyzes phosphatidylcholine to generate phosphatidic acid and choline. 5, 6 In response to a variety of upstream stimuli, including growth factors and several stress conditions, PLD2 has been known to function in a variety of biological phenomena by mediating various signaling pathways and cellular functions. 5, [7] [8] [9] [10] However, the pathophysiological roles of PLD2 in vivo have only recently been reported. [11] [12] [13] Furthermore, tissue-specific in vivo functions of PLD2 and its roles in hypoxic response have not yet been studied.
In this study, we determined that PLD2 is involved in survival, migration, and thus sprouting of ECs under hypoxic conditions. Our data suggest that PLD2 contributes to hypoxiainduced expression of HIF-1α through translational regulation and hypoxia-induced gene expression, which are important for the response of ECs to hypoxic stress. Endothelial-specific Pld2 knockout mice (eKO) showed decreased pathological angiogenesis in oxygen-induced retinopathy (OIR) and tumor implantation models. Our study demonstrated the essential role of PLD2 in the cellular processes of ECs under hypoxic stress and in pathological angiogenesis in vivo.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

PLD2 Is Required for Survival, Migration, and Sprouting of ECs Under Hypoxic Condition
To study the roles of PLD2 in angiogenesis in vivo, we produced Pld2 floxed mice with 2 LoxP sequence ( Figure IA and IB in the online-only Data Supplement). Pld2 floxed mice were then crossed with Protamine-Cre transgenic mice for whole-body deletion of Pld2, designated knockout ( Figure IA in the online-only Data Supplement). Deletion of Pld2 was confirmed by verifying protein expression using cells isolated from mice ( Figure IC in the online-only Data Supplement). Pld2 knockout mice were viable and fertile and did not exhibit detectable phenotypes compared with the wild-type littermates. We then isolated ECs from mice to determine whether ablation of Pld2 affects the cellular function of primary ECs.
ECs modulate their cellular processes, including survival, proliferation, migration, and tube formation, to generate new blood vessels during hypoxic stress. 1 To mimic hypoxiainduced angiogenesis under pathophysiological condition, we investigated whether PLD2 plays roles in the cellular functions of isolated mouse lung ECs (MLECs) under hypoxic conditions. MLECs from Pld2 knockout mice exhibited decreased survival under hypoxic conditions but no significant differences under normoxia ( Figures 1A and IIA Figure III in the onlineonly Data Supplement). We then determined whether PLD2 contributes to blood vessel growth in an ex vivo angiogenesis model. The number of endothelial sprouts and branching points from explanted aortic rings under hypoxia were reduced by PLD2 deficiency ( Figure 1C ). These data suggest that PLD2 is required for EC survival, migration, and vessel formation during hypoxic stress. performed cDNA microarray analysis to assess the gene expression induced by hypoxia in MLECs ( Figure 2A ). Differentially expressed genes were clustered by hypoxia-and PLD2-dependent pattern of gene expression, and cluster 3, corresponding to hypoxia-activated and PLD2-dependent suppressed genes, included the largest number of differentially expressed genes ( Figure 2B ; Figure IVA and Table I in the online-only Data Supplement). Functional classification showed that many genes in cluster 3 are involved in angiogenesis and related cellular processes ( Figure 2C ; Table II in the online-only Data Supplement). In the PLD2-dependent clusters (clusters 2−5), HIF-1 target genes were most enriched in cluster 3 ( Figure  IVB −IVD in the online-only Data Supplement). Quantitative real-time polymerase chain reaction data confirmed that the hypoxia-induced expression of vascular endothelial growth factor A (Vegf-a), neurotrophic tyrosine kinase receptor type2 (Ntrk2), 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (Pfkfb3), and heme oxygenase 1 (Hmox1) were inhibited in Pld2 knockout MLECs ( Figure 2D ). We also verified expression of several genes for nitric oxide synthases, cell adhesion molecules, and oxidative stress that are known to be related to angiogenesis. Among these, NADPH (nicotinamide adenine dinucleotide phosphate) oxidase 2 (Nox2) was significantly decreased by Pld2 knockout ( Figure V in the online-only Data Supplement).
Hypoxia Response Gene Expression Is
PLD2 Plays a Positive Role in Translational Control of HIF-1α Expression During Hypoxia
An increase in the amount of HIF-1α subunit is the most important mechanism for HIF-1 activation and target gene expression. 15 Therefore, we measured levels of HIF-1α in hypoxic MLECs. Consistent with the gene expression data, the increased HIF-1α protein levels induced by hypoxia were inhibited in Pld2 knockout MLECs ( Figure 3A ). Timedependent expression of HIF-1α under hypoxia was also reduced in human umbilical vein ECs after knockdown of PLD2 ( Figure 3B ). Hypoxia-induced HIF-1α expression is regulated by synthesis and degradation. To ascertain whether PLD2 contributes to HIF-1α synthesis or degradation, we measured the time-dependent kinetics of hypoxia-induced HIF-1α expression after treatment with proteasomal or translation inhibitors (MG132 and cycloheximide, respectively). When proteasomal degradation was blocked, hypoxia-induced accumulation of HIF-1α was still reduced by PLD2 knockdown ( Figure 3C ). In contrast, when translation was inhibited, silencing PLD2 did not affect HIF-1α levels ( Figure 3D ). To confirm whether PLD2 regulates the transcription of HIF-1α, we assessed HIF-1α mRNA expression, which was not altered by PLD2 knockdown ( Figure VI in the online-only Data Supplement). These data suggest that PLD2 is positively involved in the translational regulation of HIF-1α expression.
Ablation of Pld2 Decreases Retinal Angiogenesis and OIR
Retinal hypoxia plays a crucial role in retinal angiogenesis through the expression of HIF-1α and VEGF-A. 16 To assess the roles of PLD2 during in vivo physiological retinal angiogenesis, we measured retinal vascular development of wild-type and Pld2 knockout mice at postnatal day 5. Radial growth of blood vessels was delayed in retinae from Pld2 knockout mice, which showed a decreased number of tip cells and proliferative ECs ( Figure VII in the online-only Data Supplement). However, delayed retinal angiogenesis had recovered by postnatal day 14 (data not shown).
Although pathological angiogenesis shares many common processes with physiological angiogenesis, in pathological angiogenesis, formed vessels are not fully functional to resolve oxygen demand, and balance of regulatory mechanisms is disrupted. 2 Persistent angiogenesis aggravates the pathological conditions. To investigate whether endothelial PLD2 is required for angiogenesis under pathological condition, we investigated whether pathological angiogenesis occurs during OIR and tumor growth. To focus on endothelial functions of PLD2, we generated endothelial-specific KO mice, designated Pld2 eKO, by breeding Pld2 floxed mice with Tie2-Cre transgenic mice ( Figure I in the online-only Data Supplement). Pld2 floxed mice were used as the control mice in each experiment. Endothelial-specific deletion of PLD2 was confirmed by Western blot using isolated ECs and non-ECs from Pld2 eKO ( Figure ID in the online-only Data Supplement). These Pld2 eKO mice showed normal blood pressure and blood chemistry (Table III in the online-only Data Supplement). There were no significant changes in vasodilation, vasoconstriction, and vasodilatormediated blood pressure lowering ( Figure VIII in the online-only Data Supplement). In the OIR model, vascular regeneration toward the central avascular area was impaired and pathological neovascular tufts were formed by abnormal proliferation of capillary loops. Compared with control mice, Pld2 eKO retinae presented larger central avascular areas, suggesting decreased angiogenic activity toward the hypoxic avascular area ( Figure 4A ). Furthermore, Pld2 eKO mice exhibited less neovascular tuft formation, even in the more hypoxic conditions in the larger avascular areas ( Figure 4B ). Therefore, PLD2 is involved in hypoxia-mediated angiogenesis during vascular regeneration and pathological angiogenesis.
Tumor Growth and Tumor Angiogenesis Are Decreased in Pld2 eKO Mice
Angiogenesis occurs during tumor development, and it is essential for tumor growth and metastasis. 17 Furthermore, aspects of angiogenesis are highly correlated with cancer patient prognosis. HIF-1α expression driven by hypoxia, which induces the expression of several proangiogenic factors such as VEGF, is critical for tumorigenesis. In particular, endothelial expression of HIF-1α and the VEGF autocrine loop are essential components of tumor angiogenesis. 18 Therefore, we studied the roles of PLD2 in tumor angiogenesis. Lewis lung carcinoma cells were implanted subcutaneously into the midback region of mice, and tumor growth was measured. Tumor growth and weight were significantly decreased in Pld2 eKO mice compared with control mice (Figure 5A and 5B). Tumor angiogenesis was then assessed by CD31 staining of tumor slice. Blood vessel area was decreased in tumors from Pld2 eKO. The difference between control and eKO was greatest in the intratumoral region, which was more hypoxic than the tumor periphery ( Figure 5C ). Furthermore, the hypoxic region of tumor sections was larger in Pld2 eKO mice than in control ( Figure 5D ). EC proliferation and apoptosis were assessed by staining for CD31 with Ki67 or cleaved caspase-3, respectively. Significantly, fewer proliferative ECs (CD31 + Ki67 + ) were found in Pld2 eKO tumor sections, whereas the Figure 5F ). EC barrier functions and vessel leakage are related in angiogenesis. In particular, tumor blood vessels are leakier than normal vessels because of continuous remodeling; these factors are closely related to tumor prognosis and treatment. 17, 19 However, vessel leakage was not affected by deletion of endothelial PLD2 ( Figure VIIII in the online-only Data Supplement). Our data suggest that endothelial PLD2 plays a role in pathological angiogenesis during tumor development. Furthermore, PLD2 may be essential for survival and proliferation of ECs in the hypoxic tumor environment.
Discussion
Here, we report that PLD2 is required for the survival and migration of ECs, and thus for EC sprouting under hypoxia, by regulating the expression of HIF-1α at the levels of translation and target gene expression. Endothelial-specific Pld2 deletion resulted in decreased vascular regeneration and neovascular tuft formation in the OIR model. Furthermore, tumor growth in Pld2 eKO mice was reduced with decreased angiogenesis in the tumor implantation model. Taken together, these results suggest that endothelial expression of PLD2 is required for cellular response to hypoxia via HIF-1α-dependent pathway and thus is required for angiogenesis in vivo, particularly under pathological conditions (Figure 6 ). Cellular responses to hypoxic stress are mediated by multiple mechanisms, including the activation of the DNAbinding transcription factor HIF-1. 15 Under hypoxic conditions, activated HIF-1 induces the expression of several target genes that mediate various adaptive responses to oxygen tension, including angiogenesis. Under hypoxic conditions, the α-subunit of HIF-1 is synthesized, and its degradation is inhibited. Although the post-translational regulation of HIF-1α, which targets it for degradation after hydroxylation by the prolyl hydroxylase-von Hippel-Lindau protein-mediated pathway, has been well studied, HIF-1α is also transcribed and translated during hypoxia. 4 HIF-1α synthesis during hypoxia is regulated predominantly at translational level. Despite the global reduction of translation during hypoxia, 20 stress response proteins, including HIF-1α, continue to be translated. Several mechanisms for the regulation of HIF-1α translation, including internal ribosome entry site-dependent translation, 21 enhanced translation by RNA-binding proteins, 22, 23 and calcium concentration, 4, 24 have been suggested under different conditions and cell types. In addition, rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), is known to inhibit HIF-1α translation, suggesting that mTOR contributes to HIF-1α translation under hypoxia, although mTOR is inhibited during sustained hypoxia. [25] [26] [27] [28] [29] However, the exact mechanisms that regulate HIF-1α translation are unclear. In this study, PLD2 deficiency decreased the expression of a subset of hypoxia response genes, particularly HIF-1α target genes. Hypoxia-induced HIF-1α expression was reduced in MLECs and human umbilical vein ECs after the Figure 5 . Tumor growth and angiogenesis were reduced in endothelial-specific Pld2 knockout (eKO) mice. A, Implanted tumor volumes were measured every 3 days. B, Tumor weight was measured 18 days after implantation. C, Blood vessels in tumor slices were stained by CD31, and the vessel area was measured. D, Pimonidazole hydrochloride was injected into tumor-bearing mice 1 hour before tumor preparation. Hypoxic regions in tumor sections were stained with fluorescence. E and F, Proliferative or apoptotic vascular endothelial cells in tumor sections were determined by costaining with CD31 and Ki67 or cleaved caspase-3 (Casp3), respectively. Scale bar, 100 μm. *P<0.05, **P<0.01. deletion or silencing of PLD2. Furthermore, our data showing the effects of MG132 and cycloheximide implicate PLD2 in regulating HIF-1α translation. mTOR is an important regulator of protein translation, and regulation of mTOR activity by phosphatidic acid has been reported to date. 30 Especially, PLD2 is required for mTOR activity after direct interaction and localized generation of phosphatidic acid. 31 Thus, mTORdependent pathway could be one of possible mechanism for PLD2-mediated HIF-1α translation. Furthermore, in-depth analysis may reveal the details of molecular mechanism of the PLD2 contribution in translation of HIF-1α.
HIF-1α is expressed ubiquitously, and its elevated expression in cancer cells is important for tumor growth and angiogenesis. 32 In addition, endothelial expression of HIF-1α and hypoxia-driven VEGF expression are essential for EC behavior, vascular homeostasis, and pathological angiogenesis in vivo. 18, 33 Thus, endothelial knockout of HIF-1α inhibits solid tumor growth and angiogenesis. 18 Here, we showed that PLD2 is required for the survival, proliferation, migration, and thus sprouting of ECs under hypoxia. Furthermore, endothelial deletion of Pld2 decreased pathological angiogenesis in OIR and tumor models and modulated tip cell formation and EC viability. There was also a concurrent reduction in the hypoxia-induced expression of Hif-1α, Vegf-A, Pfkfb3, Ntrk2, Hmox1, and Nox2. Pfkfb3 is a glycolytic activator that regulates proliferation, filopodia/lamellipodia formation, and migration in ECs. 34 Ntrk2 is an EC survival factor that promotes vessel formation and stabilization. 35, 36 Hmox-1 protects ECs from oxidative stress and regulates placental angiogenesis. 37 Nox2 is a reactive oxygen species-producing enzyme known to be implicated in pathological angiogenesis. [38] [39] [40] [41] Collectively, our findings suggest novel roles for endothelial PLD2 in regulating hypoxia-induced HIF-1α and downstream gene expression, which contribute to the cellular response of ECs to hypoxic stress and angiogenesis. This suggests that PLD2 is a modulator of EC functions during hypoxic stress and angiogenesis under pathological conditions. Although various roles in different signaling pathways and cellular functions have been suggested, the in vivo functions of PLD2 have only recently been reported. [11] [12] [13] In addition, although PLD2 is expressed in several cell types, the tissuespecific functions of PLD2 have not been studied. Therefore, studies using tissue-specific knockout mice are required to clearly define the in vivo functions of PLD2. Angiogenesis occurs as a result of complex processes that occur in various cell types. 2 We generated endothelial-specific knockout mice to assess the endothelial roles of PLD2. Although vessel growth was delayed in Pld2 knockout retinae at postnatal day 5, the delayed retinal angiogenesis was recovered by postnatal day 14. Therefore, the effects of PLD2 deficiency may be limited in physiological angiogenesis, perhaps by compensatory mechanisms involving the other isoform, PLD1. However, Pld2 eKO mice showed significantly reduced pathological angiogenesis in an OIR model. Furthermore, tumor growth and angiogenesis were decreased in a tumor implantation model. Interestingly, our data are inconsistent with a previous study using Pld2 whole-body knockout mice, which reported that only PLD1 plays a role in the tumor microenvironment during tumor angiogenesis and metastasis. 42 Therefore, additional studies are required to clarify isoform specific-or cell type-specific functions of PLDs in angiogenic processes. Taken together, our data suggest that the in vivo functions of PLD2 could be particularly important in pathological states, although it exerts critical roles in general signaling pathways and processes. Therefore, PLD2 could be a target for development of angiogenic drugs with minimal side effects on physiological angiogenesis. Recently, PLD2-specific inhibitors were developed. 43 If effective drug for PLD2 is further developed, specific inhibition of PLD2 could be a potential clinical strategy for several diseases (cancer, diabetic retinopathy, and rheumatoid arthritis) closely related with pathological angiogenesis.
Hypoxia-mediated angiogenesis is important under pathophysiological conditions. Under pathological conditions, dysregulated angiogenesis is closely related to the progression and prognosis of several diseases including vascular retinopathy and cancer. Therefore, identifying specific factors that play roles in pathological angiogenesis is important for developing novel therapeutic strategies. Here, we showed that phospholipase D2 (PLD2) contributes to survival and migration of endothelial cells under hypoxic conditions through regulating translation of hypoxia-inducible factor-1α and expression of its target genes. Furthermore, we demonstrate roles of endothelial PLD2 in pathological angiogenesis with limited effects on physiological angiogenesis, using endothelial-specific Pld2 knockout mice. Our study suggests PLD2 as a novel regulator of pathological angiogenesis and provides new mechanistic roles of PLD2 in hypoxic response. In addition, to our knowledge, this is the first time that tissue-specific functions of PLD2 have been reported in an animal model.
Significance
